Summary
doi: 10.25005/2074-0581-2009-11-2-115-119
AEROZOL FORM OF INTERFERON Alfa-2b UNDER THE TREATMENT OF ACUTE RESPIRATORY VIRUS INFECTIONS
Clinical investigations under the treatment of acute respiratory virus infections showed that after the use of aerosol form of interferon alfa-2b the clinical symptoms (nose bloc up, nose excretion, hyperemia) were absent, and the permeability of nose ways were normalyzed, intoxication symptoms were decreased. Aerozol form of interferon has immunemodulant and high anti-virus activity; has no toxity even after treatment through respiratory ways; and has no any danger. The use of aerosol form of interferon allowed to decrease the initiation of bacterial complications under ARVI in 1,2 times.
Keywords: ARVI, aerosol form of interferon.
Materials on the topic:
- Surgical treatment of idiopathik scared stenose of trachea
- Clinical - immunological disorders in urogenital chlamydiosis in men
- Evaluation of medication «Corvitin» in complex treatment of patients with acute myocardial infarction
- Prevalence of liver cirrhosis in Tajikistan
- Results of therapy patients in acute stage of HIV infection among prisoners
- Analysis of pregnant women morbidity, such as research microelement status of women's population living in districts of town Lipetsk with different atnropotehnogenic load
- Hormonal and metabolic concept of pathogenesis prostate diseases
- MEDICINES INFLUENCING ON REGENERATION OF PERIPHERIAL NERVES
- ABDOMINOPLASTICS IN PATIENTS WITH POSTOPERATING SCARS OF FRONT ABDOMENWALL
- PROCESS OF RECANALIZATION IN YEARLY PERIOD AFTER ACUTE TROMBOPHLEBITIS OF DEEP VEINS OF LOW EXTREMITIS